1.Influence of Nursing Practice Readiness and Social Support from Clinical Nurse Educators on Reality Shock among Newly Graduated Nurses
Kyoung Hee YOUN ; Eun Hee JANG
Journal of Korean Academy of Nursing Administration 2024;30(5):494-503
Purpose:
This study aims to find ways to reduce the reality shock of newly graduated nurses by exploring the relationship between nursing practice readiness, social support from clinical nurse educators, and reality shock.
Methods:
From August 24 to September 13, 2023, data were collected from 134 newly graduated nurses with less than 12 months of clinical experience, who were trained by clinical nurse educators at one general hospital and two tertiary hospitals in I City and G Province. The data were analyzed using descriptive statistics, independent t-test, one-way analysis of variance, Pearson’s correlation coefficient, and hierarchical multiple regression with the SPSS/WIN 28.0 program.
Results:
Reality shock was negatively correlated with nursing practice readiness (r=-.50, p<.001) and social support (r=-.19, p=.03), while nursing practice readiness was positively correlated with social support (r=.37, p<.001). Nursing practice readiness was identified as a significant predictor of reality shock in newly graduated nurses (β=-.46, p<.001), accounting for 31% of the variance in reality shock (F=18.82, p<.001).
Conclusion
To alleviate the reality shock of newly graduated nurses, it is important to improve their practice readiness and ensure systematic, continuous education for clinical nurse educators.
2.Influence of Nursing Practice Readiness and Social Support from Clinical Nurse Educators on Reality Shock among Newly Graduated Nurses
Kyoung Hee YOUN ; Eun Hee JANG
Journal of Korean Academy of Nursing Administration 2024;30(5):494-503
Purpose:
This study aims to find ways to reduce the reality shock of newly graduated nurses by exploring the relationship between nursing practice readiness, social support from clinical nurse educators, and reality shock.
Methods:
From August 24 to September 13, 2023, data were collected from 134 newly graduated nurses with less than 12 months of clinical experience, who were trained by clinical nurse educators at one general hospital and two tertiary hospitals in I City and G Province. The data were analyzed using descriptive statistics, independent t-test, one-way analysis of variance, Pearson’s correlation coefficient, and hierarchical multiple regression with the SPSS/WIN 28.0 program.
Results:
Reality shock was negatively correlated with nursing practice readiness (r=-.50, p<.001) and social support (r=-.19, p=.03), while nursing practice readiness was positively correlated with social support (r=.37, p<.001). Nursing practice readiness was identified as a significant predictor of reality shock in newly graduated nurses (β=-.46, p<.001), accounting for 31% of the variance in reality shock (F=18.82, p<.001).
Conclusion
To alleviate the reality shock of newly graduated nurses, it is important to improve their practice readiness and ensure systematic, continuous education for clinical nurse educators.
3.Influence of Nursing Practice Readiness and Social Support from Clinical Nurse Educators on Reality Shock among Newly Graduated Nurses
Kyoung Hee YOUN ; Eun Hee JANG
Journal of Korean Academy of Nursing Administration 2024;30(5):494-503
Purpose:
This study aims to find ways to reduce the reality shock of newly graduated nurses by exploring the relationship between nursing practice readiness, social support from clinical nurse educators, and reality shock.
Methods:
From August 24 to September 13, 2023, data were collected from 134 newly graduated nurses with less than 12 months of clinical experience, who were trained by clinical nurse educators at one general hospital and two tertiary hospitals in I City and G Province. The data were analyzed using descriptive statistics, independent t-test, one-way analysis of variance, Pearson’s correlation coefficient, and hierarchical multiple regression with the SPSS/WIN 28.0 program.
Results:
Reality shock was negatively correlated with nursing practice readiness (r=-.50, p<.001) and social support (r=-.19, p=.03), while nursing practice readiness was positively correlated with social support (r=.37, p<.001). Nursing practice readiness was identified as a significant predictor of reality shock in newly graduated nurses (β=-.46, p<.001), accounting for 31% of the variance in reality shock (F=18.82, p<.001).
Conclusion
To alleviate the reality shock of newly graduated nurses, it is important to improve their practice readiness and ensure systematic, continuous education for clinical nurse educators.
4.Influence of Nursing Practice Readiness and Social Support from Clinical Nurse Educators on Reality Shock among Newly Graduated Nurses
Kyoung Hee YOUN ; Eun Hee JANG
Journal of Korean Academy of Nursing Administration 2024;30(5):494-503
Purpose:
This study aims to find ways to reduce the reality shock of newly graduated nurses by exploring the relationship between nursing practice readiness, social support from clinical nurse educators, and reality shock.
Methods:
From August 24 to September 13, 2023, data were collected from 134 newly graduated nurses with less than 12 months of clinical experience, who were trained by clinical nurse educators at one general hospital and two tertiary hospitals in I City and G Province. The data were analyzed using descriptive statistics, independent t-test, one-way analysis of variance, Pearson’s correlation coefficient, and hierarchical multiple regression with the SPSS/WIN 28.0 program.
Results:
Reality shock was negatively correlated with nursing practice readiness (r=-.50, p<.001) and social support (r=-.19, p=.03), while nursing practice readiness was positively correlated with social support (r=.37, p<.001). Nursing practice readiness was identified as a significant predictor of reality shock in newly graduated nurses (β=-.46, p<.001), accounting for 31% of the variance in reality shock (F=18.82, p<.001).
Conclusion
To alleviate the reality shock of newly graduated nurses, it is important to improve their practice readiness and ensure systematic, continuous education for clinical nurse educators.
5.Intermittent Fasting Modulates Immune Response by Generating Tregs via TGF-β Dependent Mechanisms in Obese Mice with Allergic Contact Dermatitis
Sang-Chul HAN ; Jung-Il KANG ; Youn Kyung CHOI ; Hye-Jin BOO ; Weon-Jong YOON ; Hee-Kyoung KANG ; Eun-Sook YOO
Biomolecules & Therapeutics 2024;32(1):136-145
People with obesity maintain low levels of inflammation; therefore, their exposure to foreign antigens can trigger an excessive immune response. In people with obesity or allergic contact dermatitis (ACD), symptoms are exacerbated by a reduction in the number of regulatory T cells (Tregs) and IL-10/TGF-β–modified macrophages (M2 macrophages) at the inflammatory site. Benefits of intermittent fasting (IF) have been demonstrated for many diseases; however, the immune responses regulated by macrophages and CD4+ T cells in obese ACD animal models are poorly understood. Therefore, we investigated whether IF suppresses inflammatory responses and upregulates the generation of Tregs and M2 macrophages in experimental ACD animal models of obese mice. The IF regimen relieved various ACD symptoms in inflamed and adipose tissues. We showed that the IF regimen upregulates Treg generation in a TGF-β-dependent manner and induces CD4+ T cell hypo-responsiveness. IF-M2 macrophages, which strongly express TGF-β and inhibit CD4+ T cell proliferation, directly regulated Treg differentiation from CD4+ T cells. These results indicate that the IF regimen enhances the TGF-β-producing ability of M2 macrophages and that the development of Tregs keeps mice healthy against ACD exacerbated by obesity. Therefore, the IF regimen may ameliorate inflammatory immune disorders caused by obesity.
6.Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Overview and Summary 2024
Young Joo PARK ; Eun Kyung LEE ; Young Shin SONG ; Bon Seok KOO ; Hyungju KWON ; Keunyoung KIM ; Mijin KIM ; Bo Hyun KIM ; Won Gu KIM ; Won Bae KIM ; Won Woong KIM ; Jung-Han KIM ; Hee Kyung KIM ; Hee Young NA ; Shin Je MOON ; Jung-Eun MOON ; Sohyun PARK ; Jun-Ook PARK ; Ji-In BANG ; Kyorim BACK ; Youngduk SEO ; Dong Yeob SHIN ; Su-Jin SHIN ; Hwa Young AHN ; So Won OH ; Seung Hoon WOO ; Ho-Ryun WON ; Chang Hwan RYU ; Jee Hee YOON ; Ka Hee YI ; Min Kyoung LEE ; Sang-Woo LEE ; Seung Eun LEE ; Sihoon LEE ; Young Ah LEE ; Joon-Hyop LEE ; Ji Ye LEE ; Jieun LEE ; Cho Rok LEE ; Dong-Jun LIM ; Jae-Yol LIM ; Yun Kyung JEON ; Kyong Yeun JUNG ; Ari CHONG ; Yun Jae CHUNG ; Chan Kwon JUNG ; Kwanhoon JO ; Yoon Young CHO ; A Ram HONG ; Chae Moon HONG ; Ho-Cheol KANG ; Sun Wook KIM ; Woong Youn CHUNG ; Do Joon PARK ; Dong Gyu NA ;
International Journal of Thyroidology 2024;17(1):1-20
Differentiated thyroid cancer demonstrates a wide range of clinical presentations, from very indolent cases to those with an aggressive prognosis. Therefore, diagnosing and treating each cancer appropriately based on its risk status is important. The Korean Thyroid Association (KTA) has provided and amended the clinical guidelines for thyroid cancer management since 2007. The main changes in this revised 2024 guideline include 1) individualization of surgical extent according to pathological tests and clinical findings, 2) application of active surveillance in low-risk papillary thyroid microcarcinoma, 3) indications for minimally invasive surgery, 4) adoption of World Health Organization pathological diagnostic criteria and definition of terminology in Korean, 5) update on literature evidence of recurrence risk for initial risk stratification, 6) addition of the role of molecular testing, 7) addition of definition of initial risk stratification and targeting thyroid stimulating hormone (TSH) concentrations according to ongoing risk stratification (ORS), 8) addition of treatment of perioperative hypoparathyroidism, 9) update on systemic chemotherapy, and 10) addition of treatment for pediatric patients with thyroid cancer.
7.Efficacy and Safety of Lurasidone vs. Quetiapine XR in Acutely Psychotic Patients With Schizophrenia in Korea: A Randomized, Double-Blind, Active-Controlled Trial
Se Hyun KIM ; Do-Un JUNG ; Do Hoon KIM ; Jung Sik LEE ; Kyoung-Uk LEE ; Seunghee WON ; Bong Ju LEE ; Sung-Gon KIM ; Sungwon ROH ; Jong-Ik PARK ; Minah KIM ; Sung Won JUNG ; Hong Seok OH ; Han-yong JUNG ; Sang Hoon KIM ; Hyun Seung CHEE ; Jong-Woo PAIK ; Kyu Young LEE ; Soo In KIM ; Seung-Hwan LEE ; Eun-Jin CHEON ; Hye-Geum KIM ; Heon-Jeong LEE ; In Won CHUNG ; Joonho CHOI ; Min-Hyuk KIM ; Seong-Jin CHO ; HyunChul YOUN ; Jhin-Goo CHANG ; Hoo Rim SONG ; Euitae KIM ; Won-Hyoung KIM ; Chul Eung KIM ; Doo-Heum PARK ; Byung-Ook LEE ; Jungsun LEE ; Seung-Yup LEE ; Nuree KANG ; Hee Yeon JUNG
Psychiatry Investigation 2024;21(7):762-771
Objective:
This study was performed to evaluate the efficacy and safety of lurasidone (160 mg/day) compared to quetiapine XR (QXR; 600 mg/day) in the treatment of acutely psychotic patients with schizophrenia.
Methods:
Patients were randomly assigned to 6 weeks of double-blind treatment with lurasidone 160 mg/day (n=105) or QXR 600 mg/day (n=105). Primary efficacy measure was the change from baseline to week 6 in Positive and Negative Syndrome Scale (PANSS) total score and Clinical Global Impressions severity (CGI-S) score. Adverse events, body measurements, and laboratory parameters were assessed.
Results:
Lurasidone demonstrated non-inferiority to QXR on the PANSS total score. Adjusted mean±standard error change at week 6 on the PANSS total score was -26.42±2.02 and -27.33±2.01 in the lurasidone and QXR group, respectively. The mean difference score was -0.91 (95% confidence interval -6.35–4.53). The lurasidone group showed a greater reduction in PANSS total and negative subscale on week 1 and a greater reduction in end-point CGI-S score compared to the QXR group. Body weight, body mass index, and waist circumference in the lurasidone group were reduced, with significantly lower mean change compared to QXR. Endpoint changes in glucose, cholesterol, triglycerides, and low-density lipoprotein levels were also significantly lower. The most common adverse drug reactions with lurasidone were akathisia and nausea.
Conclusion
Lurasidone 160 mg/day was found to be non-inferior to QXR 600 mg/day in the treatment of schizophrenia with comparable efficacy and tolerability. Adverse effects of lurasidone were generally tolerable, and beneficial effects on metabolic parameters can be expected.
8.Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
Tae-Han KIM ; In-Ho KIM ; Seung Joo KANG ; Miyoung CHOI ; Baek-Hui KIM ; Bang Wool EOM ; Bum Jun KIM ; Byung-Hoon MIN ; Chang In CHOI ; Cheol Min SHIN ; Chung Hyun TAE ; Chung sik GONG ; Dong Jin KIM ; Arthur Eung-Hyuck CHO ; Eun Jeong GONG ; Geum Jong SONG ; Hyeon-Su IM ; Hye Seong AHN ; Hyun LIM ; Hyung-Don KIM ; Jae-Joon KIM ; Jeong Il YU ; Jeong Won LEE ; Ji Yeon PARK ; Jwa Hoon KIM ; Kyoung Doo SONG ; Minkyu JUNG ; Mi Ran JUNG ; Sang-Yong SON ; Shin-Hoo PARK ; Soo Jin KIM ; Sung Hak LEE ; Tae-Yong KIM ; Woo Kyun BAE ; Woong Sub KOOM ; Yeseob JEE ; Yoo Min KIM ; Yoonjin KWAK ; Young Suk PARK ; Hye Sook HAN ; Su Youn NAM ; Seong-Ho KONG ;
Journal of Gastric Cancer 2023;23(1):3-106
Gastric cancer is one of the most common cancers in Korea and the world. Since 2004, this is the 4th gastric cancer guideline published in Korea which is the revised version of previous evidence-based approach in 2018. Current guideline is a collaborative work of the interdisciplinary working group including experts in the field of gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology and guideline development methodology. Total of 33 key questions were updated or proposed after a collaborative review by the working group and 40 statements were developed according to the systematic review using the MEDLINE, Embase, Cochrane Library and KoreaMed database. The level of evidence and the grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation proposition. Evidence level, benefit, harm, and clinical applicability was considered as the significant factors for recommendation. The working group reviewed recommendations and discussed for consensus. In the earlier part, general consideration discusses screening, diagnosis and staging of endoscopy, pathology, radiology, and nuclear medicine. Flowchart is depicted with statements which is supported by meta-analysis and references. Since clinical trial and systematic review was not suitable for postoperative oncologic and nutritional follow-up, working group agreed to conduct a nationwide survey investigating the clinical practice of all tertiary or general hospitals in Korea. The purpose of this survey was to provide baseline information on follow up. Herein we present a multidisciplinary-evidence based gastric cancer guideline.
9.Current situation and control strategies of H9N2 avian influenza in South Korea
Mingeun SAGONG ; Kwang-Nyeong LEE ; Eun-Kyoung LEE ; Hyunmi KANG ; Young Ki CHOI ; Youn-Jeong LEE
Journal of Veterinary Science 2023;24(1):e5-
The H9N2 avian influenza (AI) has become endemic in poultry in many countries since the 1990s, which has caused considerable economic losses in the poultry industry. Considering the long history of the low pathogenicity H9N2 AI in many countries, once H9N2 AI is introduced, it is more difficult to eradicate than high pathogenicity AI. Various preventive measures and strategies, including vaccination and active national surveillance, have been used to control the Y439 lineage of H9N2 AI in South Korea, but it took a long time for the H9N2 virus to disappear from the fields. By contrast, the novel Y280 lineage of H9N2 AI was introduced in June 2020 and has spread nationwide. This study reviews the history, genetic and pathogenic characteristics, and control strategies for Korean H9N2 AI. This review may provide some clues for establishing control strategies for endemic AIV and a newly introduced Y280 lineage of H9N2 AI in South Korea.
10.Erratum: Korean Practice Guidelines for Gastric Cancer 2022: An Evidencebased, Multidisciplinary Approach
Tae-Han KIM ; In-Ho KIM ; Seung Joo KANG ; Miyoung CHOI ; Baek-Hui KIM ; Bang Wool EOM ; Bum Jun KIM ; Byung-Hoon MIN ; Chang In CHOI ; Cheol Min SHIN ; Chung Hyun TAE ; Chung sik GONG ; Dong Jin KIM ; Arthur Eung-Hyuck CHO ; Eun Jeong GONG ; Geum Jong SONG ; Hyeon-Su IM ; Hye Seong AHN ; Hyun LIM ; Hyung-Don KIM ; Jae-Joon KIM ; Jeong Il YU ; Jeong Won LEE ; Ji Yeon PARK ; Jwa Hoon KIM ; Kyoung Doo SONG ; Minkyu JUNG ; Mi Ran JUNG ; Sang-Yong SON ; Shin-Hoo PARK ; Soo Jin KIM ; Sung Hak LEE ; Tae-Yong KIM ; Woo Kyun BAE ; Woong Sub KOOM ; Yeseob JEE ; Yoo Min KIM ; Yoonjin KWAK ; Young Suk PARK ; Hye Sook HAN ; Su Youn NAM ; Seong-Ho KONG
Journal of Gastric Cancer 2023;23(2):365-373

Result Analysis
Print
Save
E-mail